Abstract:Brief Description of the Purpose of the StudyTo investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions.Methods49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis.Main ResultsBiopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis.Importance of the ConclusionsFor pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions. Brief Description of the Purpose of the StudyTo investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions. To investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions. Methods49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis. 49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis. Main ResultsBiopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis. Biopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis. Importance of the ConclusionsFor pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions. For pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions.

Contrast-enhanced US-guided Percutaneous Biopsy of Anterior Mediastinal Lesions

The application of contrast enhanced ultrasound for core needle biopsy of subpleural pulmonary lesions: retrospective analysis in 92 patients

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Clinical Value of Contrast-Enhanced Ultrasound in Improving Diagnostic Accuracy Rate of Transthoracic Biopsy of Anteriormedial Mediastinal Lesions

Application of Contrast-enhanced Ultrasound to Improve the Diagnostic Accuracy Rate of Biopsy in Anterior and Middle Mediastinum Lesions

Clinical value of contrast-enhanced ultrasound in improving diagnostic accuracy rate of transthoracic biopsy of anterior-medial mediastinal lesions

Value of Contrast-Enhanced Ultrasound in Guidance of Percutaneous Biopsy in Peripheral Pulmonary Lesions

Efficacy of Contrast-Enhanced Ultrasound-Guided Percutaneous Core Needle Biopsy in Anterior Mediastinal Masses

The Role of Contrast-Enhanced Ultrasound in Selection Indication and Improveing Diagnosis for Transthoracic Biopsy in Peripheral Pulmonary and Mediastinal Lesions

Guiding and controlling percutaneous pancreas biopsies with contrast-enhanced ultrasound: target lesions are not localized on B-mode ultrasound.

Contrast-enhanced Ultrasound for Needle Biopsy of Thoracic Lesions.

Contrast-Enhanced Ultrasound Improves the Pathological Outcomes of US-Guided Core Needle Biopsy That Targets the Viable Area of Anterior Mediastinal Masses.

Identification Value of Contrast-Enhanced Sonography on Peripheral Pulmonary Cancer

ROLE OF CONTRAST-ENHANCED ULTRASOUND IN THE PRE-OPERATIVE DIAGNOSIS OF CERVICAL LYMPH NODE METASTASIS IN PATIENTS WITH PAPILLARY THYROID CARCINOMA

Comparison Of Contrast-Enhanced Ultrasound And Conventional Ultrasound For Guiding Peripheral Pulmonary Biopsies

Application of contrast-enhanced ultrasonography in improving the success rate of percutaneous biopsy for peripheral pulmonary lesions

Contrast Enhanced Ultrasound Guided Percutaneous Biopsy in Diagnosis of Pancreatic Space Occupying Lesions

Clinical Value of Ultrasound-Guided Percutaneous Biopsy of Breast Lesions

Contrast-Enhanced Ultrasound Guided Biopsy of Undetermined Abdominal Lesions: A Multidisciplinary Decision-Making Approach

Guidance and Control of Percutaneous Biopsy in Pancreatic Lesions with Contrast Enhanced Ultrasound

Application of contrast enhanced ultrasound combined biopsy in qualitative diagnosis of peripheral pulmonary lesions